Copyright 2025
Medical Security Card Company, LLC
All Rights Reserved
We take the privacy of your personal information seriously. By signing up I agree to WellRx's terms of use and privacy policy.
EVEROLIMUS/Zortress (eve ROE li mus) decreases the activity of your immune system. Afinitor is used to treat certain types of cancer. Zortress is used for kidney and liver transplant rejection prophylaxis.
Everolimus 0.5mg, Oral tablet
Grapefruit juice
· Severity: Major
· Notes for Consumers: Do not take Everolimus with grapefruit or grapefruit juice. Taking this medicine with grapefruit or grapefruit juice may increase side effects. If you accidentally take Everolimus with grapefruit or grapefruit juice, immediately tell your doctor about any unusual effects including fever, chills, cough, sore throat, pain or trouble passing urine, mouth sores, unusual bruising or bleeding, nausea, or vomiting.
· Notes for Professionals: Instruct patients to avoid grapefruit or grapefruit juice with everolimus due to the potential for increased everolimus exposure and subsequent toxicity. Everolimus is a sensitive CYP3A4 substrate and a P-glycoprotein (P-gp) substrate. Grapefruit juice is a strong CYP3A4 and P-gp inhibitor. Coadministration with another strong CYP3A4/P-gp inhibitor increased the AUC of everolimus by 15-fold.
You need to log into the site to use this feature
You may find alternative ways to save with this medication. Talk to your pharmacist about the potential option(s) noted below.
Manufacturer Coupons and Offers Available
Number of Uses:
everolimus
0.5 MG | Tablet | 60 tablets
You need to log into the site to use this feature
This feature requires registration. Sign up or log in to your free WellRx account to gain access to this and other tools to help make managing your medications and wellness easier.
Benefits Include:
This feature requires registration. Sign up or log in to your free WellRx account to gain access to this and other tools to help make managing your medications and wellness easier.
Benefits Include:
You will be redirected to your program in 5 seconds.
Our Terms and Conditions and Privacy Policy have recently been updated.
By declining you will be logged out of your account